AB
ANIK icon

Amalgamated Bank’s Anika Therapeutics ANIK Stock Holding History

Amalgamated Bank’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-392
Closed -$4K – 1686
2025
Q4 		$4K Sell
392
-105
-21% -$1.01K ﹤0.01% 2763
2025
Q3 		$5K Hold
497
– – ﹤0.01% 2735
2025
Q2 		$5K Hold
497
– – ﹤0.01% 2712
2025
Q1 		$7K Hold
497
– – ﹤0.01% 2509
2024
Q4 		$8K Hold
497
– – ﹤0.01% 2521
2024
Q3 		$12K Hold
497
– – ﹤0.01% 2348
2024
Q2 		$13K Hold
497
– – ﹤0.01% 2288
2024
Q1 		$13K Sell
497
-783
-61% -$18.9K ﹤0.01% 2307
2023
Q4 		$29K Sell
1,280
-148
-10% -$3.06K ﹤0.01% 2471
2023
Q3 		$27K Sell
1,428
-4,483
-76% -$93K ﹤0.01% 2506
2023
Q2 		$154K Sell
5,911
-183
-3% -$4.9K ﹤0.01% 1917
2023
Q1 		$175K Sell
6,094
-481
-7% -$14.3K ﹤0.01% 1856
2022
Q4 		$195K Hold
6,575
– – ﹤0.01% 1874
2022
Q3 		$156K Sell
6,575
-45
-0.7% -$1.04K ﹤0.01% 1946
2022
Q2 		$148K Buy
6,620
+192
+3% +$4.28K ﹤0.01% 2004
2022
Q1 		$161K Sell
6,428
-386
-6% -$11.8K ﹤0.01% 2024
2021
Q4 		$244K Buy
6,814
+144
+2% +$5.76K ﹤0.01% 1900
2021
Q3 		$284K Sell
6,670
-131
-2% -$5.4K ﹤0.01% 1861
2021
Q2 		$294K Buy
+6,801
New +$290K ﹤0.01% 1895

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Amalgamated Bank's ANIK Position: Q1 2026 in Review

Amalgamated Bank sold out of Anika Therapeutics (ANIK) in Q1 2026, closing a stake of 392 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in ANIK in Q2 2021 and held it in 19 quarters. The position peaked at $294K in Q2 2021. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Amalgamated Bank reported no remaining Anika Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 392 Anika Therapeutics shares in Q1 2026, an estimated $4K.
  • Amalgamated Bank first reported a position in Anika Therapeutics in Q2 2021 and held it in 19 quarters.
  • Amalgamated Bank's Anika Therapeutics position peaked at $294K in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.